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Objective. The aim oi this sludy WBS to determine the pmgmw 
tic significance of perluston-metabolism kc&g in patients un- 
dqoing positron emission lomography for mgocardial viability 
-SOlelIt. 
Background. Positron emission tomography using nitrogen.13 
ammonia and ‘“Rtwodeoxygtucme to BSSCES myocwdial blood 
Aow nnd metabolism has been shown to med!ct immwement in 
watt motion after eonmary artery ievaruitition.‘The progw 
tic implientions ef metakolii msgiog in patients with advanced 
myacnrdlum hy p&Iron emission tomography &a&d kkwd 
m&lily with many potential clinical and research appl&I 
tions in cardiology. Clinical studies (I-12) have suggested 
that it may be useful in the noninvasive diagnosis of con- 
nary artery disease (I-5). assessment of physiologic severity 
of stenosis (2,3,5), imaging of myocardii infarcts (6-10) and 
determination of myocardial viability (7-9.1 I, 12) and the 
effects ofintervention on mvoeardiai blood flow. metabolism 
and function (12). Although primarily employed as a nophis- 
ticatea nsearch tool, this technique has demonstrated clin- 
ical utility in the preoperative assessment of patients with 
advanced coronary artery disease and impaired left ventric- 
alar function considered for coronary artery revasculariza. 
!ic~. Thy combined evaluation of region?! !wxardial blood 
Row and glucose metabolism has allowed identitication of 
specific metabolic patterns that occur in ischemically com- 
promised but viable myocardium (13.14) as well as in scar 
tissue. Maintained glucose metabolism as evidenced by 
myocardial ‘BlluwedeoxygIucose uptake in segments with 
reduced blood flow has been considered as a scintigraphic 
hallmark of viable inyeanillm. whereas concordant de- 
crease of Row and atabolism is considered spccilic for scar 
tissue. 
Previous studies (12) using pasitmn emission tomography 
and the glucose analogue F-IS deoxyglucose examined R- 
gional left ventricular wall motion before and after sur@cal 
reva.sculwizatIon and con&ted these findings with preoper- 
ative metabolic imaging. Abnormal wall motion was pre- 
dieted to be reversible in regions in which positron emission 
tomography showed preserved F-18 deoxyglucose uptake 
and was predicted to be irreversible in regions with de- 
pressed F-18 deoxyglucose uptake. With use of these mite- 
ria, 75% to 85% of mycctiial segments with maintained 
F-18 droxyglucose uptake were correctly identified as Sal- 
vageable, and 78% to 92% of myocxdial segments without 
evidence of metabolic activity (12.15.16) did not recover. 
Although metabolr Imaging wth posmon cmis+x IO- 
mography has been shown to accurately predict wall motion 
recovery after revasculxiration, its prognostic utility, inde- 
pendent of treatment strategies. has not yet been estab- 
Lhed. The aim of thib study was to determine whether the 
identification of jeopardized myocardium with positron 
emission tomography predicts subsequent cardiac events 
and whether revasculan’zation affects the clinical oulcome in 
patients wilh advanced coronary anery disease and impaired 
left ventricular f!mction. We also exammed the relation 
between scintigraphic resotts and subsequent cbangc in 
functional status in this patient group. 
Methods 
Study patients. A retrospective analysis of all paiients 
who had undergone oositron emission tomomavhic mwcar- 
dial viability sc,nnin, at the University of Michigan beween 
Aueust 1988 and March 1993 was oerformed. All oatients 
had‘ known coronary artery diseaie and had unhergone 
positmn emission tomographic imaging to assess myocardnl 
wability before coronary artery revascularization. All 
were considered 10 be candidates for surgical rcvasculariza- 
tion or percutaneous transluminal coronary angioplasty 
and had a decreased left ventricular ejection fraction gnd at 
least one major vessel with significant stenosis. Patients 
were included in the study if their chart was available for 
review and telephone contact was established with the 
patient or his or her representative. One hundred ten pa- 
tients underwent positron emission tomographic viability 
studies during this time interval. Because of geographic 
considerations, complete data acquisition was not possible 
in 23 patients referred for viability studies from outside 
faciitttes. and these patients were not Included in the analy- 
sis. An additional five patients were later withdraw ‘1 because 
of electwe heart transplantation in three and poor F-18 
deoxyglucose scans that prevented adequate data interpre- 
tation in two. 
Positron emission tomogrs,:hic imaging. All patients were 
studied in the postprandial state after additional oral glucose 
loading with 50 e of elucose. Initial transmission scanninefor 
attenu&on c&e&n was performed followed by my&r- 
d!al perfusion imaging using either ‘“N.labeled ammonia or 
%bidiom. After tracer decay, IO mCi of F-18 deonyglucose 
was injected and data acquisition started 40 min after tracer 
injection. After the administration of &xv and metabolic 
tracers, 15 tramaxial planes of 6.X-mm width were obtained 
using a whole body positron emission tomographic scanner 
(SiemenslCTI 931). The transaxial image data were realinned 
to generate imnges in short-, venical~and horizontal i&g- 
axis views. Corresponding images of myocardial perfusion 
and F-18 deoxyglucose uptake in five myocardial segments 
(anterior, lateral, inferior. septum and apex) were visually 
wmpared by two observers who did not know the clinical 
data of the patients. 
scint&aphic pattern of march was deined as ai area of 
decreased blood Row and F-18 deoxyglucoae uptake invob 
ing at Icat one left ventricular segment. whereas a patten 
of mismowh was defined as an area of decreased blood Raw 
and relatively increased F-18 deoxyglucose uptake based 
on a regional sconng system involving at least one segment 
(17). Coexistence of left ventricular segments with a match 
and a mismatch pattern in a patient was considered as a 
mismatch. 
Revesculariratiun. Forty patients underwent successful 
coronary revascalarization, although one patient had a post- 
operative cardiac arrest and required placement of an artiti- 
cial heart. Six of the 40 patients underwent coronary angio 
plasty and 34 underwent coronary artery bypass grafting. 
Data acquisition. Information obtained from the charts 
included patient age. indication for and date of positron 
emission &ographic scan. indication for and date b revas- 
cularization. the number of vessels with >70% stenosis. 
cardiac risk factors (including family history of coronary 
artery disease, 210 pack-year smoking history, hypercho- 
lesterolemia, hypertension, diabetes mellitus, male gender 
and peripheral vascular occlusive disease), left ventricular 
function b:! cardiac catheterization or radionuclide ventric- 
olography; New York Heart Association functional class& 
cation for symptoms of congestive heart failure (18) and 
Canadian Card&xcular So&y classification for angina 
(19). 
Patient grouping. The patients were classified into one of 
four groups as a function of the positron emission tomo- 
graphic result and pcrfom~ance or nonperfommnce of sub- 
sequent revascularization. Gmup A comprised 18 patients 
with one or more left ventricular segments with reduced 
blcod 9w.v and preserved F-18 deoxyghtcase uptake (mis- 
match) on positron emission tomographic imaging who did 
not undergo subsequent revascularizotion. Group B com- 
prised 26 patients with a mismatch on positron emission 
tomography who underwent subsequent revascularization. 
Group C comprised 24 patients with no mismatch on 
positron emission tomogsphy who did not undergo revas- 
cularization. Group D comprised 14 patients with no mis- 
match who underwent subsequent revascularization. The 18 
patients in group A did not undergo revasculariz&tian for the 
following reasons: refusal of surgery (2 patients including I 
with onsuccessiul coronary angioplasty). pending planned 
coronary artery bypass grafting (5 patients) and physician 
judgment that the patient was appropriately managed medi- 
cally (IO patients). 
Follow-up. Pattents were interviewed by telephone an 
average of II months ailer the positron emission tomo- 
graphic imagGtg procedure. Information obtained from the 
interview by a physician (D.E.) included currem New York 
Heart Association and Canadian Cardiovascular Society 
classification for congestive heart failure and angina, respec- 
tively, subsequent myocardial infarction, death or need for 
urgent revascularization because of new symptom develop- 
ment. An event was defined as death, myocardial infarcrion. 
cardiac arrest or late revascularization because of develop- 
ment of new symptoms. The diagnosis of myocardial infarc- 
tion required increased total serum creatine kinase wit!! 
25% fraction of myosin-specific enzyme bands in the appro- 
priate clinical setting. 
statisticat snalpis. Values are presented as mean value 
L I SD. Event frequency and improvement in functional 
status among the four groups were analyzed by chi-square 
test. Group characteristics were compared by using a one- 
way analysis of variance (ANOVA) test and SchetX analysis 
for multiple comparisons. A p value < 0.05 was considtred 
signifcant. 
Results 
Patient chnrxtertstiu. The 82 patients in the final study 
group had a mean age of 59 ? 10 years. The mean left 
ventricular ejection fraction as detenined by radionuclide 
ion:dcz!ograp?.y ws 34 f 13%, the mean number of risk 
factors was 4.0 f I .O, the mean number of stenosed vessels 
was 2.1 f 0.8, the mean congestive heart failure functional 
class was 1.8 + 0.8 and the mean angina class WBS I .9 2 0.7. 
Seventy-two men and IO women were studied. 
Events (Table 1). The 82 patients entered into the study 
had 16 identified events: 9 deaths. 3 mvocardial infarctions. 
I cardiac arrest and 3 late revascul&ations. The average 
time from positron emission tomographic imaging to an 
event was 5 f 5 months for group A. 6 + 6 months for group 
B. 13 * IO months for group C and 6 months for group D. 
The 18 patients in group A (evidence of jeopardized myo. 
cardium on positron emission tomography, revascularization 
not performed) had nine events (58% event rate) including 
six deaths and three myocardial infarctions. f$ur of these 
deaths were attributed to awe myocardiat infarction; one 
death of probable cardiac oriain occurred during a hospital 
admission for a bleeding peptic ulcer and one occurred 
suddenly in the postoperative period after placement of an 
internal defibrillator. The 26 patients in grw~p B (evidence of 
jeopardized myocardium on positmn emission tomcyzphic 
imaging. revascularization performed) had three events 
(I 1.5% event rate) inc!uding one death, one perioperative 
cardiac arrest and one late revascularization. The uatient 
with perioperative arrest received an artificial he& and 
subsequently underwent rucccessfut human attomaf, trans. 
plant&n. The death in this group was attribute; to severe 
congestive heart failure. The 24 patients in group C (no 
evidence of jeopardized myocardium, revasctdarization not 
wrfomted) had three events (12.5% event rate) i&dine I 
two deaths and one late revascularization. One death was 
attributed to acute ;nyocardiat infarction and one to severe 
left ventricular failure. The I4 patients in group 3 (n, 
evidence ofjeopardized myocxdium, revascularization per- 
formed). had one event, a late revascularization (7.1% event 
rate). There was a significant diierence in the proportion of 
events between the groups CJ = 11.43, p < 0.01) (Table I). 
When group A was tested against each of the other three 
groups. the restd;s of each test were significasr :p c 0.01); 
thus the event rate in group A was greater than the event rate 
of the othsr groups. 
Croup ctwac&rist& flat&e 2). The patients in each 
group were similar with regard to age, left ventricular 
ejection fraction, number of stenased coronary arteries, 
number of risk factors and congestive heart failure classifi- 
cation. The mean angina class was higher in group B (2.5 f 
0.9) than in the other grouts (p < 0.05). These clinical 
variables did not ditier sipiscantly between the patients 
who did or did not have an event. 
Functionat ci&6eatio (T&e 3). The functional class of 
ail patients with respect to congestive heart failure and 
angina was assessed at the time of the positron emission 
tomographic scan and at an average of 12 months offollow- 
up. Only patients who did not have an event were analyzed 
for change in funnianal status. The proportion of subjects in 
each group who experienced improvement of at least one 
Table 2. Group Characteristics: Scintlgraphic Groups A Through D and Groups Wdh nnd Without Subrcquenl Events 
class w.s compared by chi-square analysis. More patients in 
group B (mismatch, revascularization) than in the other 
gmupj had improvement in angina1 and congestive heart 
failure class (,$ = 23.2, p < 0.001, respectively). 
Discussion 
Identilleation of patients lihely to benefit from coronary 
revaseularization. Our results indicate that positron emis- 
sion tomography in combination with F-18 deoxyglucose 
provides prognostic iabmmtion in patients with severely 
impaired left ventricular function. The presence of metabol- 
ically compromised myocardium. as defined by decreased 
myocardial perfusion and relatively enhanced F-18 deaxy- 
glucose uptake, identified a subgroup of patients who had a 
significantly higher rate of cardiac complications in the 
absence of coronary revascularization than that of patients 
with similar positron emission tomographic findings and 
subsequent revascularization or tmlients without evidence of 
metabolically compromised tnybcardium. The observation 
that left ventricular function, extent of coronary artery 
disease and functional class at baseline, with the exception 
ofgreater severity of angina in group 8, dtd not differ among 
these groups suggests that positron emission tomonraDhv 
may provide, independently from the established pro&& 
markers, clinical information importat for further manage- 
ment. It may be uniquely suited to identify subgroups-of 
patients with impaired left ventricular function who are 
likely to benefit from coronary revascularization. 
Each yw in rhe United States >4lM,wO patients undergo 
coronary bypass surgery or uxonary transluminal angio. 
plasty (20). Although symptomatic and prognostic benefits 
from wronary artery revascularization appear to extend to a 
large number of patients, several multicenter studies (21-23) 
performed in the 1970s demonstrated that surgery resulted in 
increased longevity only in patients with left main coronary 
artery disease or multivessel coronary artery disease with 
impaired left ventricular function. A more recent evaluation 
of medical versus surgical therapy based oil the Duke 
University experience (I%9 to 1984) found the results of 
surgical therapy to have improved with lime (24). By 1984, 
these investigators found surgical therapy to have superior 
survival benefit for most patient subgroups. Although these 
positive results for surgical revascularization are well ap- 
preciated, especially in patients with advanced coronary 
artery disease, patients with prior myocardial infarction and 
severely impaired left ventricular function are at higher risk 
for perioperative complications (25,26). In addition, an in- 
creasing number of patients with previous coronary bypass 
surgery sutTer from progression of coronary artery disease 
and require a second or third surgical revascularization. 
These procedures are technically more diRtcult and are 
associated with higher risk than that of the initial revwu- 
larization. Advances in surgical technique, including the 
OS: :i inprxed intraopentive cardioplegic protection of 
ischemic myocardium, enhances the surgical s~wess rate in 
patients with severely impaired left ventricular faction and 
allows the performance of surgery in patients previously 
considered to be unsuitable candidates for revascularization 
(24.27). 
Differentiation between scar tissue and hlbernatlng 01 
stunned mywwdium. Regional impairment of left ventticu- 
lar function in patients with ischemic heart disease does not 
necessarily represent scar tissue, but may be a result of 
hibernatingor stunned myocardium (28.29). Previous studies 
using nonsurgical and surgical revascularization have indi- 
cated that both regional and global left ventricular function 
con drammically improve aftcr revacularntion m subset> 
of patients with impaircrl fuoction. However, functional 
recovery can occur only in reversibly injured and. hence. 
viable myacardium. On the basis of ttw assumption. major 
research efforts hnve concentrated on :hc dcwlopment of 
rxhniques that provide noninvaGve markers for tiswe via- 
bility. Several rtudies 001 indicate that neither rhe degree of 
regional wall mo!ion impairment xen on echocardiography 
nor the reduction in rest myocardial blood Row adequately 
differentiates scar tissue from hxbermxmg myocardmm. 
Thallium-201 scintigraphy has been proposed (31.32) for the 
detccrinn of compromised myocardium by evahlatinq thal- 
lium-20: redistribution within exerclre-Induced perfusion 
defects. However, the specificity of this wnngraphic pat- 
tern has been challenged recently by several investigations 
(33-36) that demonstrated functional recovery in segments 
with nonredistributing thallium-201 defects. 
Prognustic role of positron emission tomography. Thrs 
smdy is the first to examine the prognosts role of positron 
emission tomography in patients with advanced coronary 
disease considered to be candidates fcr revascularization. 
Our results suggest hat, in addition to the predxtivc value of 
F-18 deoxyglucore uptake for tirrue recovery. important 
txoenostic information can be obtained from metabolic 
ima& in patients not undergoing revascularization. In the 
relatively small numbw of patients studied. the presence of 
left ventricular wgments with decressed myocardial p&u- 
sion but maintained metabolic activity, as assessed with F-18 
deoxyglucose, was associated with high nsk for cardiac 
events. This group of I8 patients experienced six cardiac 
deaths and three myocardial infarctions within the 1st I2 
months of the study. Conventional markers for cardtac risk. 
such as left ventricular ejection fraction and extent of 
coronary artery dtsease. did not differ significantly between 
this NOUD and the other three patient wmms. Therefore, _ . -. 
evidence of metabolically jeopardized myoardium may 
independently identify a pathophysiologically unstable situ- 
ation that is associated with future cardiac complications 
such as arrhythmias or myocxdia! infarction. OT both. These 
data represent further validation of metabolic imaging as a 
specific marker for jeopardized tissue in the human heart. 
The clinical outcome of patients with concordantly de- 
creased perfusion and metabolic activity in segments with 
previous infarction WBE similar in those who did or did not 
undergo revsscularization. Our study group may have been 
too small to detect a difference io outcome, which would be 
expected from previous studies in similar patients. How- 
ever, as assessed by aginal symptoms, our patient group, 
like those in previous studies, did seem to benefit from 
revarcularization. Eecause po:itron emission tomographic 
metabolic imaging is p&or& in the rest state. i! may not 
have detected myocardium at risk that would be detected by 
stress testing. This factor could account for the small degree 
of improvement of symptoms and reduction. of risk for 
events that occurred with rwascularization. Cardiac stress 
lert~ng wit\ wt mcluded in thir anaiysis. Stress-mduced 
ischemi may he an mdependem factoraffcctingprogno,,\ in 
lhcw Qauem\ Funher studier are required lo elucidate the 
Qo~rlhlc herwficwl effect5 of revascularizalion in pmiemr 
rbilh ~Cvcreiy impaired left vemr~c~lar funcuon hut rwhom 
metabolic evidence of comprom:red myacardium. 
~Trrtmicn! ansi&zratbnr. Our rtudy in a :etrosp.ecrive 
CvalMion of clinical positron Cm~won :omngraphic viabil- 
II) \!udie\ Alrhough care was taken to identify all possib!e 
fxtorr mllucncing the choice oftherapy. a selection bias not 
rCQrCrCntCd by such variables as left ventricular e,ecuon 
fraction and extent of coronary anery disrasc may have 
panI\* comnbmed to the grCatc!t~r iocldexr ofc;vd~zc CvCms 
I” patxat~ no! undergoing rcwscolwintion. In addmon. Ihe 
results of the posi::on emission tomographic scans were 
know to the physnans selecting +ticm treatment and 0~ 
knowledge may have influenced thew chmcc in some pa- 
tlents. Because such selection bias is expected to increase 
the rate of surgery in patient\ with a mismatch positron 
emission tomographic patewand hence to decrease the 
likelihood of complications in Ihis group-the prcxnce of 
wch bias would strengthen the significance of our fmdias. 
Thn first report on the prognostic information provided by 
positron emis;mn tomography reqmres confirmation in a 
lamer number of oatients. ootimally with we of a oros~ec- 
live multicenter &dy. Ho&uer,~our initial obs&&ons 
may provide the basis for improved selection of Qanents wttb 
im&&u left ver;:+xlar f&ion for revascula&ation. 
Our study did not include a comparison of positron 
emission tomography and thallium-201 scintigraphy in these 
patients. To our knowledge. no similar study has been 
performed wth thallium-201 scintigraphy and it is possible 
that !hallmm-201 redistribution pattcins identify high risk 
patients with similar prognostic power. However, our expe- 
new indicates that positron emission tomography in com- 
bination with F-18 deoxyglucose appears to provide higher 
image quaiky thandoesthallium-201 scintigraphy, especially 
in patients with severely impaired left ventricular function 
and inability to undergo exercise testing. Future studies 
Cmploymg technetium-%m-labeled blood flow tracers, 
which provide improved image quality. are required ID 
examinr the prognostic value of conventional nuclear imag- 
ing procedures for the detection ofjeopardized myocardium. 
Positron emission tomography is associated with a higher 
cost than that of conventional scintigraphic techniques. 
However, the benefit/cost ratio of this advanced imaging 
technology may bejustified on the basis of higher diagnostic 
and pmgnostic paformance if costs of subsequen: therapy 
and interventions are taken into account. 
Conclueiom. Positron emission tomography in combina- 
tion with F-13 dmxyglacose provides important climcal 
information in patients with advanced coronary artery dis- 
ease and severely impaired left ventricular Function. Com- 
parative studies with thallium-201 scintigraphy suggest hal 
positron emi&m tomography is the most accurate noninvb 
sive technique currently available :o identify viable but 
compromised myocardium. Previous data have documented 
its high predictive value for recovery of regional function 
relative to that of other techniques. This study prwides the 
first data 3” the prognostic implications of relative increased 
F-18 deoxyglucose uptake in segments with decreased myo- 
cardial perfusion. Metabolic imaging with positmn emission 
tomography nmy provide important information guiding the 
management of patients with ischemically compromised 
myocardicm. 
There data indate that patients with severely impaired 
function and metabolic evidence ofjeopardized myocardium 
are at high risk for cardiac events. If such patients cannot 
undergo revascular~~ation, either aggtrssive medical theispy 
or evaluation for cardiac transplantation may be necessary 
to reduce the risk of subsequent complication. However, 
patients without metabolic eiidence offjeopardizd myocar- 
dium bad a similar rate of complications whether 0, not 
revascularization was performed. Thus. positron emission 
tomography may be particularly useful for selecting patients 
with higher periopextive risk for necessary surgical and 
nonsurgical revaxularination. Additional studies are R- 
qdxd ?o x&m the rerubs of this study and to define the 
wwxtic wfurmznce of Dositron emission tomoeiauhic 
~e&rmanc~ in compariron’with that of other ma;ke,~ of 
tissue viability with consideration of benefitlcost ratios. 
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